What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Epilepsy
- Psychiatry
His primary areas of investigation include Epilepsy, Psychiatry, Pediatrics, Lamotrigine and Carbamazepine.
His research in Epilepsy intersects with topics in Sudden death, Incidence and Cause of death.
His work on Epilepsy syndromes, Drug development and Brivaracetam as part of general Psychiatry study is frequently linked to Ganaxolone, therefore connecting diverse disciplines of science.
His biological study spans a wide range of topics, including Epileptic seizure, Logistic regression, Epidemiology, Surgery and Case-control study.
His Lamotrigine study incorporates themes from Topiramate, Status epilepticus, Oxcarbazepine, Levetiracetam and Prospective cohort study.
His studies deal with areas such as Anesthesia and Randomized controlled trial as well as Carbamazepine.
His most cited work include:
- ILAE Official Report: A practical clinical definition of epilepsy (1947 citations)
- Epileptic seizures and epilepsy : Definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE) (1861 citations)
- ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology (1414 citations)
What are the main themes of his work throughout his whole career to date?
Torbjörn Tomson mainly focuses on Epilepsy, Pediatrics, Carbamazepine, Psychiatry and Lamotrigine.
His specific area of interest is Epilepsy, where Torbjörn Tomson studies Anticonvulsant.
His research on Pediatrics also deals with topics like
- Cause of death which intersects with area such as Young adult,
- Sudden death together with Risk factor.
As a part of the same scientific study, Torbjörn Tomson usually deals with the Carbamazepine, concentrating on Pharmacology and frequently concerns with Metabolite.
His research in Epilepsy syndromes and Depression are components of Psychiatry.
His Lamotrigine research incorporates themes from Topiramate, Adverse effect, Oxcarbazepine, Levetiracetam and Prospective cohort study.
He most often published in these fields:
- Epilepsy (77.66%)
- Pediatrics (34.36%)
- Carbamazepine (24.40%)
What were the highlights of his more recent work (between 2017-2021)?
- Epilepsy (77.66%)
- Pediatrics (34.36%)
- Intensive care medicine (13.75%)
In recent papers he was focusing on the following fields of study:
Torbjörn Tomson mostly deals with Epilepsy, Pediatrics, Intensive care medicine, Lamotrigine and Levetiracetam.
His Epilepsy study is focused on Psychiatry in general.
The various areas that Torbjörn Tomson examines in his Pediatrics study include Incidence, Valproic Acid, Congenital malformations, Antiepileptic drug and Childbearing Potential.
His Intensive care medicine study combines topics in areas such as Unexpected death and Prescribed drugs.
The Lamotrigine study combines topics in areas such as Endocrinology and Carbamazepine.
His research investigates the connection between Levetiracetam and topics such as Prospective cohort study that intersect with problems in Phenytoin, Oxcarbazepine and Topiramate.
Between 2017 and 2021, his most popular works were:
- Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry (152 citations)
- Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry (152 citations)
- Clinical risk factors in SUDEP: A nationwide population-based case-control study. (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Epilepsy
- Psychiatry
His main research concerns Epilepsy, Pediatrics, Childbearing Potential, Lamotrigine and Levetiracetam.
His Epilepsy study integrates concerns from other disciplines, such as Absolute risk reduction, Young adult, Tolerability, Death certificate and Autopsy.
The study incorporates disciplines such as Odds ratio, Cohort study, Cause of death, Stroke and Hazard ratio in addition to Absolute risk reduction.
Torbjörn Tomson combines subjects such as Valproic Acid, Congenital malformations and Antiepileptic drug with his study of Pediatrics.
Torbjörn Tomson interconnects Seizure control, Quality of life, Menopause, Hormone metabolism and Vitamin D and neurology in the investigation of issues within Childbearing Potential.
His Lamotrigine research integrates issues from Topiramate, Carbamazepine, Oxcarbazepine, Prospective cohort study and Phenytoin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
